Biodegradable Hemostat Market Reaches $1.63 Billion In 2026: Key Developments Shaping Expansion
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Biodegradable Hemostat Market Set To Climb From $1.08 Billion In 2026 To $1.63 Billion By 2030
The biodegradable hemostat market size has experienced rapid expansion in recent years. This market is projected to increase from $0.97 billion in 2025 to $1.08 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.3%. Historically, this growth has been driven by factors including the reliance on conventional non-absorbable hemostats, a rise in surgical procedure volumes, the expansion of hospital infrastructure, increased awareness of blood loss management, and the adoption of basic wound care technologies.
The biodegradable hemostat market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $1.63 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.8%. This projected increase during the forecast period is fueled by progress in polymer and biomaterial science, an increase in minimally invasive surgical interventions, a rise in trauma and emergency incidents, more regulatory authorizations for biodegradable medical devices, and the proliferation of ambulatory surgical centers. Key developments anticipated over the forecast timeframe encompass the increasing integration of absorbable hemostatic solutions, a growing inclination towards biocompatible and bioabsorbable substances, expanded application in minimally invasive and laparoscopic operations, the broader deployment of advanced hemostats in trauma and urgent care settings, and a heightened demand for hemostatic products that are ready-to-use and straightforward to apply.
Get A Free Sample Report With In-Depth Market Insights:
Biodegradable Hemostat Market Industry Drivers: What’s Behind The Revenue Growth?
The escalating volume of surgical interventions is projected to drive the expansion of the biodegradable hemostat market in the future. These medical operations, carried out by healthcare professionals utilizing specialized instruments, aim to treat, repair, or remove bodily components for health improvement. The uptick in surgical procedures is largely linked to a rise in chronic conditions, which frequently require surgical management to resolve health issues and improve patient outcomes. Biodegradable hemostats present an advantage during surgeries because they naturally degrade within the body after application, thus negating the need for removal and decreasing the likelihood of post-operative complications. For instance, in January 2025, Intuitive Surgical Inc., a US-based medical device company, stated that OUS general surgery procedures grew by roughly 35% in 2024, following an increase of about 42% in 2023. Colorectal procedures represented the largest part of this incremental volume during both years. Thus, the increasing occurrence of surgical procedures is propelling the growth of the biodegradable hemostat market.
Biodegradable Hemostat Market Segment Outlook: Which Categories Are Growing Fastest?
The biodegradable hemostat market covered in this report is segmented –
1) By Product Type: Natural Polymer-Based Hemostats, Synthetic Polymer-Based Hemostats, Composite Hemostats, Cellulose-Based Hemostats, Gelatin-Based Hemostats
2) By Formulation: Powdered Hemostats, Granular Hemostats, Liquid Hemostats, Foam Hemostats, Film Or Sheet Hemostats
3) By Application: Surgical Procedures, Trauma Procedures, Dental Procedures, Laparoscopic Procedures, Other Applications
4) By Distribution Channel: Direct Sales, Distributors, E-Commerce Platforms, Pharmaceutical Retailers, Healthcare Supply Companies
5) By End-User: Hospitals, Ambulatory Surgical Centers, Clinics, Research Laboratories, Other End Users
Subsegments:
1) By Natural Polymer-Based Hemostats: Collagen-Based, Chitosan-Based, Alginate-Based, Fibrin-Based, Dextran-Based
2) By Synthetic Polymer-Based Hemostats: Polyethylene Glycol (PEG)-Based, Polyurethane-Based, Polylactic Acid (PLA)-Based, Polyglycolic Acid (PGA)-Based, Polycaprolactone (PCL)-Based
3) By Composite Hemostats: Natural-Synthetic Polymer Blends, Polymer-Cellulose Composites, Polymer-Gelatin Composites, Multi-Layer Composites, Nano-Composite Hemostats
4) By Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC), Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Nanocellulose-Based, Hydroxypropyl Cellulose (HPC)
5) By Gelatin-Based Hemostats: Porcine Gelatin-Based, Bovine Gelatin-Based, Fish Gelatin-Based, Cross-Linked Gelatin, Modified Gelatin Formulations
#Biodegradable Hemostat Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the biodegradable hemostat market are prioritizing the development of advanced solutions, such as the plant-based cellulose matrix, aimed at quickly stopping bleeding and reducing blood loss. A plant-based cellulose matrix is a naturally occurring material derived from plant fibers, serving as a biodegradable support structure frequently employed in medical environments because it can be safely absorbed by the body. For example, in April 2024, LifeScience PLUS, a US-based medical device company, introduced DonorSeal, a distinct hemostatic dressing made entirely from plant-sourced cellulose. Upon contact with blood, DonorSeal forms a gel that effectively controls bleeding, while being fully biodegradable, absorbable, non-toxic, and pH neutral, thus safe for patients even those on blood thinners. It assists in maintaining a moist and soothing setting that promotes natural tissue regeneration. The dressing is easily removable without causing the wound to reopen or adhere, offering enhanced comfort and a quicker recovery for donor site wounds.
Biodegradable Hemostat Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the biodegradable hemostat market are Johnson And Johnson Services Inc, Medtronic Plc, Stryker Corporation, Baxter International Inc, Meril Life Sciences Pvt Ltd, Samyang Holdings Corp, Molnlycke Health Care AB, GELITA Medical GmbH, B Braun Melsungen AG, Tricol Biomedical Inc, Hemostasis LLC, Cura Medical, RevMedx Inc, Speed Care Mineral GmbH, Regenity, C R Bard Inc, Integra LifeSciences Corporation, Advanced Medical Solutions Group plc, Anika Therapeutics Inc, Marine Polymer Technologies Inc, Axio Biosolutions Pvt Ltd, Biom Up Inc
View The Full Biodegradable Hemostat Market Report:
Biodegradable Hemostat Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the biodegradable hemostat market in 2025. The regions covered in the biodegradable hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
